GNPX NASDAQ
Genprex, Inc.
1W: -20.1%
1M: -25.1%
3M: -80.8%
YTD: -93.3%
1Y: -98.7%
3Y: -100.0%
5Y: -100.0%
$2.63
+0.07 (+2.73%)
Weekly Expected Move ±11.8%
$2
$2
$3
$3
$3
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
10 relationships10
As Filer
counterparties named
0
As Counterparty
mentioned by others
3
Rel. Types
2022-11-28
Earliest Filing
2025-06-11
Latest Filing
licensee: 8
acquirer: 1
investor: 1
Counterparties (Filed by GNPX)
10 relationshipsCompanies named in GNPX's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| GENPREX, INC. | GNPX | acquirer | Company selling common stock to investor | 2025-06-11 | View |
| LINCOLN PARK CAPITAL FUND, LLC | — | investor | Investor purchasing common stock from company | 2025-06-11 | View |
| University of Pittsburgh – Of the Commonwealth System of Higher Education | — | licensee | Licensor of patent rights and know-how for diabetes therapy | 2025-02-18 | View |
| Genprex, Inc. | GNPX | licensee | Licensee granted exclusive rights to develop and commercialize licensed technology | 2025-02-18 | View |
| University of Pittsburgh | — | licensee | Owner of patent rights and know-how granting an exclusive license for diabetes therapy. | 2023-07-18 | View |
| Genprex, Inc. | GNPX | licensee | Company obtaining an exclusive license to develop and commercialize diabetes therapy technology. | 2023-07-18 | View |
| University of Pittsburgh – Of the Commonwealth System of Higher Education | — | licensee | University of Pittsburgh grants exclusive license for diabetes therapy patent rights and know-how | 2023-01-05 | View |
| Genprex, Inc. | GNPX | licensee | Genprex, Inc. obtains exclusive license for diabetes therapy patent rights and know-how | 2023-01-05 | View |
| University of Pittsburgh – Of the Commonwealth System of Higher Education | — | licensee | University of Pittsburgh grants exclusive license for diabetes therapy patent rights and know-how | 2022-11-28 | View |
| Genprex, Inc. | GNPX | licensee | Genprex, Inc. obtains exclusive license to develop and commercialize diabetes therapy technology | 2022-11-28 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-18 | Other Events; Exhibits | View | |
| 2026-08-05 | Delisting Notice; Exhibits | View | |
| 2026-08-03 | Other Events; Exhibits | View | |
| 2026-07-30 | Delisting Notice; Other Events; Exhibits | View | |
| 2026-07-14 | Bylaws Amendment; Regulation FD; Other Events; Exhibits | View | |
| 2026-06-22 | Other Events; Exhibits | View | |
| 2026-06-18 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-06-12 | Delisting Notice; Other Events; Exhibits | View | |
| 2026-05-26 | Other Events; Exhibits | View | |
| 2026-05-14 | Other Events; Exhibits | View | |
| 2026-04-30 | Other Events; Exhibits | View | |
| 2026-04-28 | Other Events; Exhibits | View | |
| 2026-04-21 | Regulation FD; Other Events; Exhibits | View | |
| 2026-02-23 | Other Events; Financial Statements and Exhibits | View | |
| 2026-02-10 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-09 | Other Events; Financial Statements and Exhibits | View | |
| 2026-01-07 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2026-01-06 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-23 | Other Events; Financial Statements and Exhibits | View | |
| 2025-11-26 | Notice of Delisting or Transfer; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR